SARP | NHLBI Trans-Omics for Precision Medicine

SARP

Progress Report

Status report for COVID-19 Genetic Risk Score and associations with COVID-19 related outcomes: the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program and the C4R Study

Progress Report

Status report for Associations of polygenic risk scores for chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis susceptibility with COVID-19 related hospitalization and death: the C4R study

Progress Report

Status report for Increasing genetic and environmental diversity: Multi-ancestry genome-wide study of tobacco and alcohol use in 6.5 million individuals (Prop ID:17628)

Abstracts associated with this proposal

Rare variants affecting telomere length and disease identified through multi-omic modeling

Progress Report

Status report for Watershed multi-omics modeling to identify rare variants affecting telomere length (Prop ID:17322)

Progress Report

Status report for Assessing genetic determinants of telomere length leveraging whole genome sequence data in the NHLBI Trans-Omics for Precision Medicine Program – breakout proposal for PRS. (Prop ID:16887)

Progress Report

Status report for Patterns of ultra-rare genetic variation from high coverage whole genome sequencing of over 150,000 diverse people. (Prop ID:16344)

Progress Report

Status report for Polymorphisms in oxidative stress related gene and environmental effects in asthma (Prop ID:15906)

Progress Report

Status report for Polymorphisms in oxidative stress related gene and environmental effects in asthma (Prop ID:15905)

Progress Report

Status report for Characterizing the Structural Variations in Cardiomyopathy Associated Genes in the NHLBI TOPMed Program (Prop ID:14705)

Progress Report

Status report for Prevalence and Association of Putative Pathogenic Genetic Variants Predisposing to Inherited Cardiomyopathies in a Multi-Ethnic Population (Prop ID:14647)